Clinical Trials Browser

Phase 2 × Liposarcoma × efatutazone × Clear all

NCT02249949 2025-01-27

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Phase 2 Completed

15 enrolled 12 charts

Liposarcoma